Organon & Co.
OGN
$13.31
-$0.02-0.15%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -2.08% | -2.92% | -1.69% | -1.02% | -0.84% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -2.08% | -2.92% | -1.69% | -1.02% | -0.84% |
| Cost of Revenue | 5.92% | 5.58% | 4.41% | 3.46% | 3.31% |
| Gross Profit | -8.04% | -9.07% | -6.05% | -4.20% | -3.71% |
| SG&A Expenses | -0.86% | -1.72% | 4.17% | -2.18% | -3.82% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.11% | 0.35% | 2.49% | -0.30% | -0.83% |
| Operating Income | -13.06% | -13.63% | -14.39% | -3.51% | -0.84% |
| Income Before Tax | -20.09% | -47.34% | -10.23% | 1.68% | -0.30% |
| Income Tax Expenses | 473.08% | 517.54% | 138.73% | 90.14% | 79.09% |
| Earnings from Continuing Operations | -67.20% | -78.36% | -61.49% | -30.00% | -28.37% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -67.20% | -78.36% | -61.49% | -30.00% | -28.37% |
| EBIT | -13.06% | -13.63% | -14.39% | -3.51% | -0.84% |
| EBITDA | -6.89% | -6.76% | -7.92% | 1.01% | 2.39% |
| EPS Basic | -67.52% | -78.50% | -61.89% | -30.57% | -28.91% |
| Normalized Basic EPS | -15.62% | -18.73% | -21.66% | -4.68% | 0.28% |
| EPS Diluted | -67.62% | -78.63% | -62.10% | -31.03% | -29.67% |
| Normalized Diluted EPS | -15.19% | -18.41% | -21.55% | -4.81% | -0.02% |
| Average Basic Shares Outstanding | 0.98% | 0.95% | 0.91% | 0.86% | 0.79% |
| Average Diluted Shares Outstanding | 0.45% | 0.52% | 0.81% | 1.06% | 1.17% |
| Dividend Per Share | -92.86% | -69.64% | -46.43% | -23.21% | 0.00% |
| Payout Ratio | -0.77% | 0.37% | 0.39% | 0.11% | 0.43% |